Canlyniadau Chwilio - Timo D. Müller

Mireinio'r Canlyniadau
  1. 1
    The molecular pharmacology of glucagon agonists in diabetes and obesity

    The molecular pharmacology of glucagon agonists in diabetes and obesity gan Aaron Novikoff, Timo D. Müller

    Cyhoeddwyd 2023
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    (Patho)Physiology of Glycosylphosphatidylinositol-Anchored Proteins I: Localization at Plasma Membranes and Extracellular Compartments

    (Patho)Physiology of Glycosylphosphatidylinositol-Anchored Proteins I: Localization at Plasma Membranes and Extracellular Compartments gan Günter Müller, Timo D. Müller

    Cyhoeddwyd 2023
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Antagonizing GIPR adds fire to the GLP-1R flame

    Antagonizing GIPR adds fire to the GLP-1R flame gan Aaron Novikoff, Timo D. Müller

    Cyhoeddwyd 2024
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Incretin hormones and type 2 diabetes

    Incretin hormones and type 2 diabetes gan Michael A. Nauck, Timo D. Müller

    Cyhoeddwyd 2023
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Therapeutic Potential of Targeting the Ghrelin Pathway

    Therapeutic Potential of Targeting the Ghrelin Pathway gan Gustav Colldén, Matthias H. Tschöp, Timo D. Müller

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Ghrelin regulation of glucose metabolism

    Ghrelin regulation of glucose metabolism gan Anne-Laure Poher, Matthias H. Tschöp, Timo D. Müller

    Cyhoeddwyd 2018
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Gut hormone polyagonists for the treatment of type 2 diabetes

    Gut hormone polyagonists for the treatment of type 2 diabetes gan Sara J. Brandt, A. Götz, Matthias H. Tschöp, Timo D. Müller

    Cyhoeddwyd 2018
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Dual and Triple Incretin-Based Co-agonists: Novel Therapeutics for Obesity and Diabetes

    Dual and Triple Incretin-Based Co-agonists: Novel Therapeutics for Obesity and Diabetes gan Robert M. Gutgesell, Rubén Nogueiras, Matthias H. Tschöp, Timo D. Müller

    Cyhoeddwyd 2024
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Anti-obesity drug discovery: advances and challenges

    Anti-obesity drug discovery: advances and challenges gan Timo D. Müller, Matthias Blüher, Matthias H. Tschöp, Richard D. DiMarchi

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Ghrelin and its potential in the treatment of eating/wasting disorders and cachexia

    Ghrelin and its potential in the treatment of eating/wasting disorders and cachexia gan Timo D. Müller, Diego Pérez–Tilve, Jenny Tong, Paul T. Pfluger, Matthias H. Tschöp

    Cyhoeddwyd 2010
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Anti-Obesity Therapy: from Rainbow Pills to Polyagonists

    Anti-Obesity Therapy: from Rainbow Pills to Polyagonists gan Timo D. Müller, Christoffer Clemmensen, Brian Finan, Richard D. DiMarchi, M. Tschöp

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Glucagon Regulation of Energy Expenditure

    Glucagon Regulation of Energy Expenditure gan Maximilian Kleinert, Stephan Sachs, Kirk M. Habegger, Susanna M. Hofmann, Timo D. Müller

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Peptide‐based multi‐agonists: a new paradigm in metabolic pharmacology

    Peptide‐based multi‐agonists: a new paradigm in metabolic pharmacology gan Sara J. Brandt, Timo D. Müller, Richard D. DiMarchi, M. Tschöp, Kerstin Stemmer

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Glucagon's Metabolic Action in Health and Disease

    Glucagon's Metabolic Action in Health and Disease gan Anja Zeigerer, Revathi Sekar, Maximilian Kleinert, Shelly Nason, Kirk M. Habegger, Timo D. Müller

    Cyhoeddwyd 2021
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Gut-Brain Cross-Talk in Metabolic Control

    Gut-Brain Cross-Talk in Metabolic Control gan Christoffer Clemmensen, Timo D. Müller, Stephen C. Woods, Hans-Rudolf Berthoud, Randy J. Seeley, Matthias H. Tschöp

    Cyhoeddwyd 2017
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    GLP-1/glucagon receptor co-agonism for treatment of obesity

    GLP-1/glucagon receptor co-agonism for treatment of obesity gan Miguel A. Sánchez-Garrido, Sara J. Brandt, Christoffer Clemmensen, Timo D. Müller, Richard D. DiMarchi, Matthias H. Tschöp

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    GIPR/GLP-1R dual agonist therapies for diabetes and weight loss—chemistry, physiology, and clinical applications

    GIPR/GLP-1R dual agonist therapies for diabetes and weight loss—chemistry, physiology, and clinical applications gan Jonathan E. Campbell, Timo D. Müller, Brian Finan, Richard D. DiMarchi, Matthias H. Tschöp, David A. D’Alessio

    Cyhoeddwyd 2023
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Unimolecular Polypharmacy for Treatment of Diabetes and Obesity

    Unimolecular Polypharmacy for Treatment of Diabetes and Obesity gan Matthias H. Tschöp, Brian Finan, Christoffer Clemmensen, Vasily M. Gelfanov, Diego Pérez–Tilve, Timo D. Müller, Richard D. DiMarchi

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Recent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and Diabetes

    Recent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and Diabetes gan Qiming Tan, Seun Akindehin, Camila E. Orsso, Richelle C. Waldner, Richard D. DiMarchi, Timo D. Müller, Andrea M. Haqq

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    'Fat mass and obesity associated' gene (FTO): No significant association of variant rs9939609 with weight loss in a lifestyle intervention and lipid metabolism markers in German obese children and adolescents

    'Fat mass and obesity associated' gene (FTO): No significant association of variant rs9939609 with weight loss in a lifestyle intervention and lipid metabolism markers in German ob... gan Timo D. Müller, Anke Hinney, André Scherag, Thuy Trang Nguyen, Felix Schreiner, H. Schäfer, Johannes Hebebrand, Christian L. Roth, Thomas Reinehr

    Cyhoeddwyd 2008
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: